[Influenza season 1998/99; composition of vaccine for 1999/2000].
Identifieur interne : 000450 ( Main/Exploration ); précédent : 000449; suivant : 000451[Influenza season 1998/99; composition of vaccine for 1999/2000].
Auteurs : G F Rimmelzwaan [Pays-Bas] ; J C De Jong ; A I Bartelds ; J W Dorigo-Zetsma ; R A Fouchier ; A D OsterhausSource :
- Nederlands tijdschrift voor geneeskunde [ 0028-2162 ] ; 1999.
Descripteurs français
- KwdFr :
- Grippe humaine (prévention et contrôle), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains (MeSH), Organisation mondiale de la santé (MeSH), Orthomyxoviridae (pathogénicité), Pays-Bas (épidémiologie), Recommandations comme sujet (MeSH), Surveillance de la population (MeSH), Vaccins antigrippaux (ressources et distribution), Vaccins combinés (ressources et distribution).
- MESH :
- pathogénicité : Orthomyxoviridae.
- prévention et contrôle : Grippe humaine.
- ressources et distribution : Vaccins antigrippaux, Vaccins combinés.
- virologie : Grippe humaine.
- épidémiologie : Grippe humaine, Pays-Bas.
- Humains, Organisation mondiale de la santé, Recommandations comme sujet, Surveillance de la population.
- Wicri :
- geographic : Pays-Bas.
English descriptors
- KwdEn :
- Guidelines as Topic (MeSH), Humans (MeSH), Influenza Vaccines (supply & distribution), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (virology), Netherlands (epidemiology), Orthomyxoviridae (pathogenicity), Population Surveillance (MeSH), Vaccines, Combined (supply & distribution), World Health Organization (MeSH).
- MESH :
- chemical , supply & distribution : Influenza Vaccines, Vaccines, Combined.
- geographic , epidemiology : Netherlands.
- epidemiology : Influenza, Human.
- pathogenicity : Orthomyxoviridae.
- prevention & control : Influenza, Human.
- virology : Influenza, Human.
- Guidelines as Topic, Humans, Population Surveillance, World Health Organization.
Abstract
The first indication of influenza activity in the Netherlands in the 1998/'99 season was the isolation of an influenza B virus in week 47 of 1998. In subsequent weeks influenza activity slowly increased, reaching a peak in week 6 of 1999. After a gradual decline for three weeks a second peak was reached in week 8 of 1999. The first wave of influenza activity was primarily caused by influenza B viruses, whereas during the second wave predominantly influenza A viruses of the A/H3N2 subtype were isolated. The antigenic properties of the influenza A viruses resembled those of the viruses isolated in the previous season and the vaccine strain A/Sydney/5/97. The influenza B viruses did not completely match with B/Harbin/7/94 which is most commonly used for vaccine production. The vaccine, however, did provide good protection against the epidemic strains of influenza. This season influenza A/H1N1 viruses did not play a significant part and only a small number of viruses of this subtype were isolated at the end of the season. For the influenza season 1999/2000 it is recommended by the World Health Organization that the vaccines contain the following (or similar) virus strains: A/Sydney/5/97 (H3N2), A/Beijing/262/95 (H1N1) and B/Beijing/184/93.
PubMed: 10535060
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Influenza season 1998/99; composition of vaccine for 1999/2000].</title><author><name sortKey="Rimmelzwaan, G F" sort="Rimmelzwaan, G F" uniqKey="Rimmelzwaan G" first="G F" last="Rimmelzwaan">G F Rimmelzwaan</name><affiliation wicri:level="3"><nlm:affiliation>Nationaal Influenza Centrum van de Wereldgezondheidsorganisatie, Erasmus Universiteit, afd. Virologie, Rotterdam.</nlm:affiliation><country>Pays-Bas</country><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName><wicri:orgArea>Nationaal Influenza Centrum van de Wereldgezondheidsorganisatie, Erasmus Universiteit, afd. Virologie</wicri:orgArea></affiliation></author><author><name sortKey="De Jong, J C" sort="De Jong, J C" uniqKey="De Jong J" first="J C" last="De Jong">J C De Jong</name></author><author><name sortKey="Bartelds, A I" sort="Bartelds, A I" uniqKey="Bartelds A" first="A I" last="Bartelds">A I Bartelds</name></author><author><name sortKey="Dorigo Zetsma, J W" sort="Dorigo Zetsma, J W" uniqKey="Dorigo Zetsma J" first="J W" last="Dorigo-Zetsma">J W Dorigo-Zetsma</name></author><author><name sortKey="Fouchier, R A" sort="Fouchier, R A" uniqKey="Fouchier R" first="R A" last="Fouchier">R A Fouchier</name></author><author><name sortKey="Osterhaus, A D" sort="Osterhaus, A D" uniqKey="Osterhaus A" first="A D" last="Osterhaus">A D Osterhaus</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1999">1999</date><idno type="RBID">pubmed:10535060</idno><idno type="pmid">10535060</idno><idno type="wicri:Area/Main/Corpus">000452</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000452</idno><idno type="wicri:Area/Main/Curation">000452</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000452</idno><idno type="wicri:Area/Main/Exploration">000452</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Influenza season 1998/99; composition of vaccine for 1999/2000].</title><author><name sortKey="Rimmelzwaan, G F" sort="Rimmelzwaan, G F" uniqKey="Rimmelzwaan G" first="G F" last="Rimmelzwaan">G F Rimmelzwaan</name><affiliation wicri:level="3"><nlm:affiliation>Nationaal Influenza Centrum van de Wereldgezondheidsorganisatie, Erasmus Universiteit, afd. Virologie, Rotterdam.</nlm:affiliation><country>Pays-Bas</country><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName><wicri:orgArea>Nationaal Influenza Centrum van de Wereldgezondheidsorganisatie, Erasmus Universiteit, afd. Virologie</wicri:orgArea></affiliation></author><author><name sortKey="De Jong, J C" sort="De Jong, J C" uniqKey="De Jong J" first="J C" last="De Jong">J C De Jong</name></author><author><name sortKey="Bartelds, A I" sort="Bartelds, A I" uniqKey="Bartelds A" first="A I" last="Bartelds">A I Bartelds</name></author><author><name sortKey="Dorigo Zetsma, J W" sort="Dorigo Zetsma, J W" uniqKey="Dorigo Zetsma J" first="J W" last="Dorigo-Zetsma">J W Dorigo-Zetsma</name></author><author><name sortKey="Fouchier, R A" sort="Fouchier, R A" uniqKey="Fouchier R" first="R A" last="Fouchier">R A Fouchier</name></author><author><name sortKey="Osterhaus, A D" sort="Osterhaus, A D" uniqKey="Osterhaus A" first="A D" last="Osterhaus">A D Osterhaus</name></author></analytic><series><title level="j">Nederlands tijdschrift voor geneeskunde</title><idno type="ISSN">0028-2162</idno><imprint><date when="1999" type="published">1999</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Guidelines as Topic (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (supply & distribution)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Influenza, Human (virology)</term><term>Netherlands (epidemiology)</term><term>Orthomyxoviridae (pathogenicity)</term><term>Population Surveillance (MeSH)</term><term>Vaccines, Combined (supply & distribution)</term><term>World Health Organization (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (virologie)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Organisation mondiale de la santé (MeSH)</term><term>Orthomyxoviridae (pathogénicité)</term><term>Pays-Bas (épidémiologie)</term><term>Recommandations comme sujet (MeSH)</term><term>Surveillance de la population (MeSH)</term><term>Vaccins antigrippaux (ressources et distribution)</term><term>Vaccins combinés (ressources et distribution)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Influenza Vaccines</term><term>Vaccines, Combined</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Netherlands</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins combinés</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Pays-Bas</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Guidelines as Topic</term><term>Humans</term><term>Population Surveillance</term><term>World Health Organization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Organisation mondiale de la santé</term><term>Recommandations comme sujet</term><term>Surveillance de la population</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Pays-Bas</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The first indication of influenza activity in the Netherlands in the 1998/'99 season was the isolation of an influenza B virus in week 47 of 1998. In subsequent weeks influenza activity slowly increased, reaching a peak in week 6 of 1999. After a gradual decline for three weeks a second peak was reached in week 8 of 1999. The first wave of influenza activity was primarily caused by influenza B viruses, whereas during the second wave predominantly influenza A viruses of the A/H3N2 subtype were isolated. The antigenic properties of the influenza A viruses resembled those of the viruses isolated in the previous season and the vaccine strain A/Sydney/5/97. The influenza B viruses did not completely match with B/Harbin/7/94 which is most commonly used for vaccine production. The vaccine, however, did provide good protection against the epidemic strains of influenza. This season influenza A/H1N1 viruses did not play a significant part and only a small number of viruses of this subtype were isolated at the end of the season. For the influenza season 1999/2000 it is recommended by the World Health Organization that the vaccines contain the following (or similar) virus strains: A/Sydney/5/97 (H3N2), A/Beijing/262/95 (H1N1) and B/Beijing/184/93.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10535060</PMID><DateCompleted><Year>1999</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-2162</ISSN><JournalIssue CitedMedium="Print"><Volume>143</Volume><Issue>40</Issue><PubDate><Year>1999</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Nederlands tijdschrift voor geneeskunde</Title><ISOAbbreviation>Ned Tijdschr Geneeskd</ISOAbbreviation></Journal><ArticleTitle>[Influenza season 1998/99; composition of vaccine for 1999/2000].</ArticleTitle><Pagination><MedlinePgn>2015-8</MedlinePgn></Pagination><Abstract><AbstractText>The first indication of influenza activity in the Netherlands in the 1998/'99 season was the isolation of an influenza B virus in week 47 of 1998. In subsequent weeks influenza activity slowly increased, reaching a peak in week 6 of 1999. After a gradual decline for three weeks a second peak was reached in week 8 of 1999. The first wave of influenza activity was primarily caused by influenza B viruses, whereas during the second wave predominantly influenza A viruses of the A/H3N2 subtype were isolated. The antigenic properties of the influenza A viruses resembled those of the viruses isolated in the previous season and the vaccine strain A/Sydney/5/97. The influenza B viruses did not completely match with B/Harbin/7/94 which is most commonly used for vaccine production. The vaccine, however, did provide good protection against the epidemic strains of influenza. This season influenza A/H1N1 viruses did not play a significant part and only a small number of viruses of this subtype were isolated at the end of the season. For the influenza season 1999/2000 it is recommended by the World Health Organization that the vaccines contain the following (or similar) virus strains: A/Sydney/5/97 (H3N2), A/Beijing/262/95 (H1N1) and B/Beijing/184/93.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rimmelzwaan</LastName><ForeName>G F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Nationaal Influenza Centrum van de Wereldgezondheidsorganisatie, Erasmus Universiteit, afd. Virologie, Rotterdam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Jong</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Bartelds</LastName><ForeName>A I</ForeName><Initials>AI</Initials></Author><Author ValidYN="Y"><LastName>Dorigo-Zetsma</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Fouchier</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Osterhaus</LastName><ForeName>A D</ForeName><Initials>AD</Initials></Author></AuthorList><Language>dut</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><VernacularTitle>Het influenzaseizoen 1998/'99; vaccinsamenstelling voor 1999/2000.</VernacularTitle></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ned Tijdschr Geneeskd</MedlineTA><NlmUniqueID>0400770</NlmUniqueID><ISSNLinking>0028-2162</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017778">Vaccines, Combined</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Ned Tijdschr Geneeskd. 1999 Oct 2;143(40):1988-91</RefSource><PMID Version="1">10535054</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017408" MajorTopicYN="N">Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000600" MajorTopicYN="Y">supply & distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017778" MajorTopicYN="N">Vaccines, Combined</DescriptorName><QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>10</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>2</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>10</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10535060</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country><region><li>Hollande-Méridionale</li></region><settlement><li>Rotterdam</li></settlement></list><tree><noCountry><name sortKey="Bartelds, A I" sort="Bartelds, A I" uniqKey="Bartelds A" first="A I" last="Bartelds">A I Bartelds</name><name sortKey="De Jong, J C" sort="De Jong, J C" uniqKey="De Jong J" first="J C" last="De Jong">J C De Jong</name><name sortKey="Dorigo Zetsma, J W" sort="Dorigo Zetsma, J W" uniqKey="Dorigo Zetsma J" first="J W" last="Dorigo-Zetsma">J W Dorigo-Zetsma</name><name sortKey="Fouchier, R A" sort="Fouchier, R A" uniqKey="Fouchier R" first="R A" last="Fouchier">R A Fouchier</name><name sortKey="Osterhaus, A D" sort="Osterhaus, A D" uniqKey="Osterhaus A" first="A D" last="Osterhaus">A D Osterhaus</name></noCountry><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Rimmelzwaan, G F" sort="Rimmelzwaan, G F" uniqKey="Rimmelzwaan G" first="G F" last="Rimmelzwaan">G F Rimmelzwaan</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000450 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000450 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippePaysBasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:10535060
|texte= [Influenza season 1998/99; composition of vaccine for 1999/2000].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:10535060" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippePaysBasV1
| This area was generated with Dilib version V0.6.35. |  |